Related Experiment Video
Updated: Jun 21, 2026
08:27
Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
Distinct neuroinflammatory profile in post-mortem human Huntington's disease
Aurelio Silvestroni1, Richard L M Faull, Andrew D Strand
1Department of Neurology bCenter for Neurogenetics and Neurotherapeutics, School of Medicine, University of Washington, Seattle, Washington 98195, USA.
Neuroreport
|July 11, 2009
Summary
Neuroinflammation is evident in Huntington's disease, particularly in the striatum. Key inflammatory mediators were also upregulated in the cortex and cerebellum, suggesting novel therapeutic targets.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Neuroinflammation is a hallmark of neurodegenerative diseases.
- Its role in Huntington's disease (HD) remains largely unexplored.
- HD primarily affects the striatum, but other brain regions may also be involved.
Purpose of the Study:
- To investigate the presence and extent of neuroinflammation in Huntington's disease.
- To compare the expression of neuroinflammation-associated mediators in post-mortem brain samples from HD patients and controls.
- To identify potential brain regions and molecular targets for therapeutic intervention in HD.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) was employed.
- Expression levels of key inflammatory mediators were analyzed.
- Post-mortem brain tissues from the striatum, cortex, and cerebellum of HD patients and controls were used.
Main Results:
- Increased expression of CCL2 and IL-10 was observed specifically in the striatum of HD patients.
- Upregulation of IL-6, IL-8, and MMP9 was detected in the cortex and cerebellum of HD patients.
- These findings indicate widespread neuroinflammation in HD, even in regions not typically considered primary affected areas.
Conclusions:
- Neuroinflammation is a significant feature of Huntington's disease.
- The identified inflammatory mediators and affected brain regions present potential novel therapeutic targets.
- Further research into neuroinflammation could lead to new treatment strategies for HD.
